Request Deal Involvement

A consortium of investors completed a $180m investment in Spyre Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

TD Cowen

financial advisors

TD Cowen

Evercore

financial advisors

Evercore

Stifel

financial advisors

Stifel

Guggenheim Partners

financial advisors

Guggenheim Partners

LifeSci Partners

financial advisors

LifeSci Partners

or

Principals

AVIDITY PARTNERS

bidder

AVIDITY PARTNERS

ADAGE CAPITAL PARTNERS

bidder

ADAGE CAPITAL PARTNERS

LOGOS CAPITAL

bidder

LOGOS CAPITAL

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

FARALLON CAPITAL MANAGEMENT LLC

bidder

FARALLON CAPITAL MANAGEMENT LLC

BOXER CAPITAL

bidder

BOXER CAPITAL

SPYRE THERAPEUTICS

target

SPYRE THERAPEUTICS

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

DARWIN GLOBAL MANAGEMENT

bidder

DARWIN GLOBAL MANAGEMENT

RTW INVESTMENTS

bidder

RTW INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - A consortium of investors completed a $180m investment in Spyre Therapeutics.